Austin, TXNCT07070115Now EnrollingIRB Ready

Hiatal Hernia Clinical Trial in Austin, TX

Access cutting-edge hiatal hernia treatment through this clinical trial at a research site in Austin. Study-provided care at no cost to qualified participants.

Sponsored by Tela Bio Inc

Quick Self-Assessment

See if you qualify for this Austin location

Preparing your pre-screening questions…

Expert Care in Austin

Access hiatal hernia specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related hiatal hernia treatment provided free

Apply for This Austin Location

Check if you qualify for this hiatal hernia clinical trial in Austin, TX

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Austin

    Convenient for TX residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Austin site if eligible
  4. 4Begin participation

About This Hiatal Hernia Study in Austin

This study will evaluate hiatal hernia recurrence rate and post-operative complications following the use of OviTex Core Resorbable or OviTex 1S Resorbable.

Sponsor: Tela Bio Inc

Who Can Participate

Inclusion Criteria

Patient is a candidate for an elective robotic or laparoscopic primary hiatal hernia repair with the use of OviTex Core Resorbable or OviTex 1S Resorbable.
Patient is willing and able to voluntarily sign the IRB-approved Informed Consent Form for the study.
Patient is at least 22 years old at the time of surgery.
Patient is not pregnant and not planning to become pregnant during the duration of the study (5 years).
Patient is able and willing to comply with the study requirements including completion of patient questionnaires and clinic evaluations.

Exclusion Criteria

(Baseline):
Patient has a Body Mass Index (BMI) of ≥ 35.
Patient meets the Centers for Disease Control (CDC) Surgical Site Infection (SSI) Wound Classification Class IV (Dirty-Infected) criteria.
Patient has a Type I hiatal hernia (defined as only the esophagogastric junction is above the diaphragm).
Patient has a life expectancy of less than five years making it unlikely that the subject will successfully achieve five-year follow-up.
Patient is a current nicotine user (including smokeless, vaporized, etc.)
Patient has a history of illicit drug or alcohol abuse (in the last three years).
Patient has an allergy to ovine-derived products or a known sensitivity to polyglycolic acid (PGA).
Patient has an allergy to barium.
Patient's surgery will include the use of an anti-reflux implantable device (LINX, etc.).
Patient's surgery requires the use of an additional mesh device or a pledget for reinforcement.
Patient has participated in another gastrointestinal (GI) clinical study within the past 30 days or is currently involved in another clinical study excluding observational and registry studies.
Patient had previous surgery at the gastroesophageal junction.
Patient had a prior hiatal hernia repair.
Patient has an incarcerated hernia that requires emergent intervention.
Patient is a prisoner. Exclusion Criteria (Intra-operative):
Patient is unable to receive OviTex Core Resorbable or OviTex 1S Resorbable at time of surgery.
Surgery requires the use of an additional mesh device or a pledget for reinforcement.
Surgery includes the use of an anti-reflux implantable device (LINX, etc.).
Surgery performed as an open procedure.
Patient has a condition, which in the Investigator's opinion, may put the patient at increased risk, confound study data, or interfere significantly with the patient's participation in the study.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Austin?

Yes, this clinical trial (NCT07070115) has an active research site in Austin, TX that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Hiatal Hernia Treatment Options in Austin, TX

If you're searching for hiatal hernia treatment options in Austin, TX, this clinical trial (NCT07070115) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Austin research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hiatal hernia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Ready to Join in Austin?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Austin, TX